NCT05600322 2024-10-03
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Photocure
Phase 3 Completed
Clinical Trials
10 trialsNCT02560584 2018-07-02
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Photocure
Phase 3 Completed
NCT00785694 2015-04-24
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
GE Healthcare
Phase 4 Withdrawn
NCT00052637 2013-10-23
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
Photocure
Phase 3 Completed
NCT01344902 2013-10-23
An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon
Photocure
Phase 1/2 Terminated
NCT00233402 2013-10-11
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Photocure
Phase 3 Completed
NCT00412971 2013-10-11
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
Photocure
Phase 3 Completed
NCT00708942 2013-04-24
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Photocure
Phase 2 Terminated
NCT01551407 2012-10-25
Detection of Bladder Tumors After 30 Min Instillation of Hexvix
Photocure
Phase 2 Terminated
NCT00285701 2010-01-15
Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study
Photocure
Phase 1/2 Completed